EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Enhancement of Intracellular Cholesterol Efflux in Chondrocytes Leading to Alleviation of Osteoarthritis Progression

Gyuseok Lee, Jiye Yang, Su-Jin Kim, Thanh-Tam Tran, Sun Young Lee, Ka Hyon Park, Seung-Hee Kwon, Ki-Ho Chung, Jeong-Tae Koh, Yun Hyun Huh, Jong-Keun Seon iD, Hyun Ah Kim und 2 weitere

Arthritis & Rheumatology · 2025-02 · 77 (2) · 151-162

DOI: 10.1002/art.42984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 29.09.2024. Verfasst von Gyuseok Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Chonnam National University, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Chondrocytes, Cholesterol, Anticholesteremic Agents, Osteoarthritis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Korean Fund for Regenerative Medicine, Korean government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Osteoarthritis (OA) is the most common degenerative disease worldwide, with no practical means of prevention and limited treatment options. Recently, our group unveiled a novel mechanism contributing to OA pathogenesis in association with abnormal cholesterol metabolism in chondrocytes. In this study, we aimed to establish a clinical link between lipid profiles and OA in humans, assess the effectiveness of cholesterol‐lowering drugs in suppressing OA development in mice, and uncover the cholesterol‐lowering mechanisms that effectively impede OA progression.

Methods

Five clinically approved cholesterol‐lowering drugs (fenofibrate, atorvastatin, ezetimibe, niacin, and lomitapide) were injected into the knee joints or administered with diet to mice with OA who underwent destabilization of the medial meniscus induction and were fed a 2% high‐cholesterol diet. Gene expression linked to cholesterol metabolism was determined using microarray analysis. Furthermore, the in vivo functions of these genes were explored through intra‐articular injection of either its inhibitor or adenovirus.

Results

Logistic regression analysis confirmed a close relationship between the diagnostic criteria of hyperlipidemia based on serum lipid levels and OA incidence. Among the cholesterol‐lowering drugs examined, fenofibrate exerted the most significant protective effect against cartilage destruction, which was attributed to elevated levels of high‐density lipoprotein cholesterol that are crucial for cholesterol efflux. Notably, cholesterol efflux was suppressed during OA progression via down‐regulation of apolipoprotein A1–binding protein (AIBP) expression. Overexpression of AIBP effectively inhibits OA progression.

Conclusion

Our results suggest that restoration of cholesterol homeostasis to a normal state through administration of fenofibrate or AIBP overexpression, both of which induce cholesterol efflux, offers an effective therapeutic option for patients with OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesCholesterolAnticholesteremic AgentsOsteoarthritisOsteoarthritis, KneeAnimalsDisease ProgressionMiceHumansAtorvastatinEzetimibeFenofibrateMaleNiacinMice, Inbred C57BLBenzimidazoles

Substanzen

CholesterolAnticholesteremic AgentsAtorvastatinEzetimibeFenofibrateNiacinBenzimidazoles

Autor:innen und Institutionen

  • Chonnam National University, Gwangju, Republic of Korea.
  • Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
  • Chonnam National University Hwasun Hospital and Medical School, Hwasun, Republic of Korea.
  • Hallym University, Sacred Heart Hospital, Anyang, Republic of Korea.

ORCID-Profile: Jong-Keun Seon, Jang-Soo Chun, Je-Hwang Ryu

Förderung

  • National Research Foundation of Korea
  • Korean Fund for Regenerative Medicine
  • Korean government
  • Ministry of Science and ICT, the Ministry of Health and Welfare

Zitieren

APA

Lee, G., Yang, J., Kim, S. J., Tran, T. T., Lee, S. Y., Park, K. H., Kwon, S. H., Chung, K. H., Koh, J. T., Huh, Y. H., Seon, J. K., Kim, H. A., Chun, J. S., & Ryu, J. H. (2025). Enhancement of Intracellular Cholesterol Efflux in Chondrocytes Leading to Alleviation of Osteoarthritis Progression. Arthritis & Rheumatology, 77(2), 151-162. https://doi.org/10.1002/art.42984

Vancouver

Lee G, Yang J, Kim SJ, Tran TT, Lee SY, Park KH, et al. Enhancement of Intracellular Cholesterol Efflux in Chondrocytes Leading to Alleviation of Osteoarthritis Progression. Arthritis & Rheumatology. 2025;77(2):151-162. doi:10.1002/art.42984

BibTeX
@article{Lee2025,
  author = {Lee, Gyuseok and Yang, Jiye and Kim, Su-Jin and Tran, Thanh-Tam and Lee, Sun Young and Park, Ka Hyon and Kwon, Seung-Hee and Chung, Ki-Ho and Koh, Jeong-Tae and Huh, Yun Hyun and Seon, Jong-Keun and Kim, Hyun Ah and Chun, Jang-Soo and Ryu, Je-Hwang},
  title = {Enhancement of Intracellular Cholesterol Efflux in Chondrocytes Leading to Alleviation of Osteoarthritis Progression},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  volume = {77},
  number = {2},
  pages = {151--162},
  doi = {10.1002/art.42984}
}
Kostenlos starten →